首页> 外文期刊>Neuroscience Letters: An International Multidisciplinary Journal Devoted to the Rapid Publication of Basic Research in the Brain Sciences >The temporal localization of frame-shift ubiquitin-B and amyloid precursor protein, and complement proteins in the brain of non-demented control patients with increasing Alzheimer's disease pathology.
【24h】

The temporal localization of frame-shift ubiquitin-B and amyloid precursor protein, and complement proteins in the brain of non-demented control patients with increasing Alzheimer's disease pathology.

机译:非痴呆对照患者的阿尔茨海默氏病病理学增加,移码的泛素B和淀粉样蛋白前体蛋白以及补体蛋白在时间上的定位。

获取原文
获取原文并翻译 | 示例
           

摘要

Transcriptional misreading of dinucleotide repeats that generates deletions in RNA and produces frame-shift proteins with loss of function has been reported in Alzheimer's disease (AD). Here frame-shift ubiquitin-B and amyloid precursor protein were immunochemically shown to exist in the brain of high pathology control (HPC) patients with AD pathology but without prior dementia. These proteins were absent in low pathology control patients with limited AD pathology and no dementia. Since the HPC patients can be regarded as preclinical AD patients, our results suggest the accumulation of these proteins involved in the initial steps of AD pathogenesis. By contrast, complement proteins were detected in the AD patients, whereas only trace amounts were found in the HPC patients, indicating the involvement of complement proteins in the later stage of AD dementia.
机译:在阿尔茨海默氏病(AD)中,已报道了二核苷酸重复序列的转录错误读物,该错误会在RNA中产生缺失并产生移码蛋白质,但功能丧失。在这里,移码的泛素-B和淀粉样蛋白前体蛋白通过免疫化学方法显示在患有AD病理但没有痴呆的高病理对照(HPC)患者的大脑中。这些蛋白质在AD病理受限且无痴呆的低病理对照患者中不存在。由于HPC患者可以被视为临床前AD患者,因此我们的结果表明这些蛋白的积累参与了AD发病的初始步骤。相反,在AD患者中检测到补体蛋白,而在HPC患者中仅发现痕量,这表明补体蛋白参与了AD痴呆的晚期。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号